Ultravist 370 and Zosyn drug interactions - a phase IV clinical study of FDA data
Summary:
We study 11,570 people who take Ultravist 370 (iopromide) and Zosyn (piperacillin sodium; tazobactam sodium). There is no drug interaction reported.
The study analyzes what interactions people have when they take Ultravist 370 and Zosyn. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Ultravist 370?
Ultravist 370 has active ingredients of iopromide. eHealthMe is studying from 1,334 Ultravist 370 users. Check the latest studies of Ultravist 370.
What is Zosyn?
Zosyn has active ingredients of piperacillin sodium; tazobactam sodium. It is often used in pneumonia. eHealthMe is studying from 10,236 Zosyn users. Check the latest studies of Zosyn.
No report is found.
Do you take Ultravist 370 and Zosyn?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ultravist 370 (1,334 reports)
- Zosyn (10,236 reports)
How the study uses the data?
The study uses data from the FDA. It is based on iopromide and piperacillin sodium; tazobactam sodium (the active ingredients of Ultravist 370 and Zosyn, respectively), and Ultravist 370 and Zosyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Novorapid and Myoclonus for Women aged 60+ - 5 seconds ago
- Could Lamotrigine cause Generalized Anxiety Disorder? - 6 seconds ago
- Drug interactions of Zubsolv and Profen - 7 seconds ago
- Abdominal Pain and drugs of ingredients of pyrimethamine - 9 seconds ago
- Could Paclitaxel cause Chronic Thyroiditis? - 18 seconds ago
- Macular Degeneration and drugs of ingredients of mometasone furoate - 31 seconds ago
- Perindopril Erbumine and Profen drug interactions for women aged 40-49 - 31 seconds ago
- Sleep Disorder and drugs of ingredients of buprenorphine - 32 seconds ago
- Could Meloxicam cause Hyperkalemia? - 39 seconds ago
- Therapeutic Response Unexpected With Drug Substitution and drugs of ingredients of lorazepam - 40 seconds ago